Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment

Artif Cells Nanomed Biotechnol. 2016;44(2):588-95. doi: 10.3109/21691401.2014.971806. Epub 2014 Oct 30.

Abstract

This study utilized the Seahorse Analyzer to examine the effect of the bile acid ursodeoxycholic acid (UDCA), on the morphology, swelling, stability, and size of novel microencapsulated β-cells, in real-time. UDCA was conjugated with fluorescent compounds, and its partitioning within the microcapsules was examined using confocal microscopy. UDCA produced microcapsules with good morphology, better mechanical strength (p < 0.01), and reduced swelling properties (p < 0.01), but lower cell viability (p < 0.05) and cell count per microcapsule (p < 0.01). UDCA reduced the cells' biochemical activities, mitochondrial respiration, and energy production, post-microencapsulation. This is the first time biological functions of microencapsulated β-cells have been analyzed in real-time.

Keywords: Seahorse analyzer; bile acid; microencapsulation; pancreatic beta cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Capsules
  • Cell Line
  • Cell Respiration / drug effects
  • Cell Survival / drug effects
  • Chemistry, Pharmaceutical
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / pathology*
  • Drug Stability
  • Fluorescent Dyes / chemistry
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / pathology
  • Mechanical Phenomena
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Ursodeoxycholic Acid / chemistry*
  • Ursodeoxycholic Acid / pharmacology*
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Capsules
  • Fluorescent Dyes
  • Ursodeoxycholic Acid